| Brian Grancagnolo is a skilled communications professional with more than 15 years’ experience developing programming that activates key stakeholders and achieves key business objectives. Brian’s healthcare experience spans a number of categories and sectors and includes deep engagements in oncology, rare disease, neurology and immunology.
Helping to lead H+K’s U.S. Health practice, Brian combines his sector expertise with an understanding of the evolving health landscape to support clients with needs for both corporate and product communications. Currently, Brian oversees work across a broad group of clients, including engagements with BioPharma companies such as Janssen, Takeda and Merck, and leading health providers like Weill Cornell Medicine. Leading H+K’s work with Merck for the past five years, Brian has directed programing for a number of campaigns and milestones across the Insomnia, Hospital and Allergy franchises. As part of his work with Shire (now Takeda), Brian partnered with the leadership of the Immunology franchise to develop the franchise identity as a key component of the company’s rare disease focus. Brian’s experience also includes leading engagements for the Amgen Oncology franchise, and clients like Otsuka Pharmaceutical with activities focused on raising the profile of the company’s global tuberculosis franchise. Before joining the firm, Brian oversaw healthcare and consumer public relations campaigns at Rowland Communications Worldwide (Publicis) for companies in the BioPharma, health IT, and medical device industries. Brian received his undergraduate degree in marketing from Villanova University. |